Medtronic, Inc. (MDT) Expands Availability of Valiant(R) Captivia(R) Stent Graft in Major Global Markets  
5/9/2012 10:12:06 AM

MINNEAPOLIS--(BUSINESS WIRE)--Increasing patient access to endovascular repair of aortic aneurysms worldwide, Medtronic, Inc. (NYSE: MDT) is expanding availability of the Valiant® Captivia® Thoracic Stent Graft System in several countries, including China, Japan and the United States.